| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10821187 | JOURNEY | Compositions, gels and foams with rheology modulators and uses thereof |
Oct, 2030
(6 years from now) | |
| US10137200 | JOURNEY | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
Oct, 2030
(6 years from now) | |
| US8865139 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
| US10265404 | JOURNEY | Compositions, gels and foams with rheology modulators and uses thereof |
Oct, 2030
(6 years from now) | |
| US8992896 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
| US9675700 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
| US10086080 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
| US10517882 | JOURNEY | Method for healing of an infected acne lesion without scarring |
Oct, 2030
(6 years from now) | |
| US10213512 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
| US8945516 | JOURNEY | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
Oct, 2030
(6 years from now) | |
| US10398641 | JOURNEY | Compositions and methods for treating rosacea and acne |
Sep, 2037
(13 years from now) | |
| US10849847 | JOURNEY | Compositions and methods for treating rosacea and acne |
Sep, 2037
(13 years from now) | |
Amzeeq is owned by Journey.
Amzeeq contains Minocycline Hydrochloride.
Amzeeq has a total of 12 drug patents out of which 0 drug patents have expired.
Amzeeq was authorised for market use on 18 October, 2019.
Amzeeq is available in aerosol, foam;topical dosage forms.
Amzeeq can be used as treatment of non-nodular acne vulgaris.
The generics of Amzeeq are possible to be released after 08 September, 2037.
Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient
Market Authorisation Date: 18 October, 2019
Treatment: Treatment of non-nodular acne vulgaris
Dosage: AEROSOL, FOAM;TOPICAL
AMZEEQ family patents
